Challenges and Perspectives on Neglected Diseases in Developing Countries
Author Information
Author(s): Boutayeb Abdesslam
Primary Institution: UFR Modelling and Data Analysis, Faculty of Sciences-University Mohamed Ier, Oujda, Morocco
Conclusion
Urgent actions are needed to develop new drugs and vaccines that are efficient and accessible for neglected diseases affecting poor populations in developing countries.
Supporting Evidence
- Neglected diseases affect almost exclusively extremely poor populations living in remote areas.
- These diseases cause severe disabilities and affect over a billion people worldwide.
- Less than 10% of biomedical research funds are dedicated to the diseases affecting 90% of the world's burden.
Takeaway
Many people in developing countries suffer from diseases that are often ignored because they are not profitable to treat. We need to find better ways to help these people get the medicines they need.
Potential Biases
The focus on profitable diseases may overshadow the needs of those suffering from neglected diseases.
Limitations
The article discusses the lack of attention and funding for neglected diseases but does not provide specific data on the effectiveness of proposed solutions.
Participant Demographics
The populations affected are primarily extremely poor individuals living in remote areas of developing countries.
Want to read the original?
Access the complete publication on the publisher's website